Author Question: Many stroke patients are candidates for thrombolytic drugs. One of the most important things that an ... (Read 79 times)

dollx

  • Hero Member
  • *****
  • Posts: 558
Many stroke patients are candidates for thrombolytic drugs. One of the most important things that an EMT can do to optimize the care of a stroke patient who is a candidate for the drugs is:
 
  A) transport to the closest hospital since the patient must go to the operating room as soon as possible.
  B) determine the exact time of onset of symptoms.
  C) do a thorough physical exam of the patient.
  D) transport the patient to a Level I Trauma Center.

Question 2

The trachea branches off at the ________ and forms two mainstem bronchi.
 
  A) carina B) bronchioles C) alveoli D) pleura



Mholman93

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

B

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library